Publication Name	World Journal of Gastroenterology
Manuscript ID	10818
Country	Egypt

Received	2014-04-21 11:33
Peer-Review Started	2014-04-21 19:00
To Make the First Decision	2014-05-13 20:31
Return for Revision	2014-05-21 08:51
Revised	2014-05-24 00:00
Second Decision	2014-07-11 16:56
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-07-11 17:27
Articles in Press	2014-07-11 17:36
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-08-23 20:42
Typeset the Manuscript	2014-12-11 16:55
Publish the Manuscript Online	2015-01-06 09:08

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Biology
Manuscript Type	Autobiography
Article Title	Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease
Manuscript Source	Unsolicited Manuscript
All Author List	Abeer A Bahnassy, Abdel-Rahman N Zekri, Ahmed El-Bastawisy, Amal Fawzy, Marwa Shetta, Nehal Hussein, Dalia Omran, Abdallah A S Ahmed and Samir S El-Labbody
Funding Agency and Grant Number
Corresponding Author	Abeer A Bahnassy, MD, PhD, Professor, Molecular Pathology Unit, Pathology Department, National Cancer Institute, Cairo University, Fom El Khalig, Cairo 11796, Egypt. chaya2000@hotmail.com
Key Words	Cancer stem cells; Circulating tumor cells; Hepatitis C virus genotype-4; Hepatocellular carcinoma
Core Tip	Recent studies have shown that cancer stem and circulating tumor cells contribute to tumor development and progression and can predict patient outcome. Although there are various methods for enumeration of circulating tumor cells, this study demonstrates that flow cytometry is a sensitive, rapid and easy technique that can be used to follow chronic hepatitis C virus patients for early detection of hepatocellular carcinoma. Additionally, telomerase, melanoma antigen encoding gene 3 and cancer stem cell markers (CD90, CD133, CK19) are prognostic indicators in hepatocellular carcinoma patients.
Publish Date	2015-01-06 09:08
Citation	Bahnassy AA, Zekri ARN, El-Bastawisy A, Fawzy A, Shetta M, Hussein N, Omran D, Ahmed AAS, El-Labbody SS. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease. World J Gastroenterol 2014; 20(48): 18240-18248
URL	http://www.wjgnet.com/1007-9327/full/v20/i48/18240.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i48.18240

Full Article (PDF)	WJG-20-18240.pdf
Full Article (Word)	WJG-20-18240.doc
Manuscript File	10818-Review.doc
Answering Reviewers	10818-Answering reviewers.pdf
Copyright License Agreement	10818-Copyright assignment.pdf
Peer-review Report	10818-CrossCheck.jpg
Scientific Misconduct Check	10818-CrossCheck.jpg
Scientific Editor Work List	10818-Scientific editor work list.pdf